Doctor Anca Daniela Farcas
University of Medicine and Pharmacy of Cluj Napoca, Cluj Napoca (Romania)
Member of:
/f/125658/3386x1417/951de003e4/hfa-acronym-name-rgb.png)
Could diastolic perfomance parameters be earlier markers for cardiotoxicity in high risk cancer patients?
Event: ESC Congress 2020
Topic: Cardio-Oncology
Session: Cardiovascular Disease in Special Populations ePosters
The role of ST2 as an early marker of endothelial dysfunction in hypertensive patients
Event: ESC Congress 2019
Topic: Target Organ Damage/Left Ventricular Hypertrophy
Session: Hypertension mediated target organ damage and hypertension phenotypes
Plasma levels of ST2 - predictive factor of unfavourable outcome in hypertensive patients
Event: ESC Congress 2018
Topic: Epidemiology, Prognosis, Outcome
Session: Hypertension treatment old and new
Heart failure with mid-range ejection fraction - an echocardiographic finding or a clinical phenotype?
Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure
Topic: Chronic pulmonary hypertension
Session: Chronic heart failure
Metoprolol and carvedilol in heart failure - different mechanisms, similar effect?
Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure
Topic: Beta blockers
Session: Beta blockers
Improving blood pressure control beyond the guidelines
Event: ESC Congress 2016
Topic: Treatment of hypertension
Session: Drug treatment of hypertension
The lymphocyte count and neutrophil/lymphocyte ratio as independent predictors for cardiac events in heart failure only in ischemic heart disease patients
Event: HEART FAILURE 2016
Topic: Inflammation
Session: Biomarkers
